MediPharm Labs Expands CBN Portfolio with Two New Products
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects.
- A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects.
- New CBN products include CBN:CBD 1:2 Relax Formula Oil and a Northbound high CBN and high CBD vape cartridge.
- BARRIE, Ontario, Nov. 23, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (MediPharm Labs or the Company) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the expansion of its unique cannabinol (CBN) product line.
- This is an exciting addition to our wellness line of products which is produced to a pharmaceutical quality standard in a GMP licensed facility, said Bryan Howcroft, CEO, MediPharm Labs.